From early-stage biotechnology start-ups to large multinational pharmaceuticals, the life sciences industry relies on innovation to meet shifting demands in health and improve treatment outcomes around the globe. However, emerging and established risks force organizations to operate in a volatile environment. While navigating research and development challenges, supply chain impacts and barriers to commercial sales, businesses also find themselves swept up in the fight for talent.
Finding new ways to cost-effectively manage risk and attract and retain a digitally-savvy workforce will accelerate innovation to create greater efficiencies, develop personalized medical treatments and access new markets. But with ever-evolving regulation, governance and production interruptions impacting the pace of progress, businesses across this sector must be resilient, investing in end-to-end solutions for their risk and human capital, as well as workforce health and wellbeing to protect vital talent.
Report
From the global powerhouses of big pharma to the niche start-ups and technology giants venturing into the healthtech space, technology has transformed the opportunities and risks for life sciences businesses. Both innovation and digitalization have been fundamental for the research, production and distribution of medicine and medical devices.
Article
Organisations recognize the growing value of technology and data assets relative to historical tangible assets, but they spend four times more budget on insurance for Property, Plant & Equipment risks
Article
How Cyber and Data Resilience Support Growth in Life Sciences
Article
While digitalization is delivering transformational change to R&D across the sector, it is also rapidly reshaping recruitment and retention strategies.
You will soon receive an email to verify your email address. Please click on the link included in this note to complete the subscription process, which also includes providing consent in applicable locations and an opportunity to manage your email preferences.
Article 5 Min Read
Article 10 Min Read
Your request is being reviewed so we can align you to the best resources on our team. In the meantime, we invite you to explore some of our latest insights below.
Article 5 Min Read
Article 10 Min Read
